Acknowledgements
Halkes
We thank the Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) for providing data from the HOVON-43 trial. We thank Dr. R.J. van de Peppel, Prof. Dr. O.M. Dekkers, Dr. C.J.M. Halkes, Prof. Dr. J.H. Veelken, Dr. A.H.W. Bruns,  Prof. Dr. F. van de Veerdonk and Dr. B.J.A. Rijnders for their contribution in study conceptualisation.